Neurological and respiratory effects of lung protective ventilation in acute brain injury patients without lung injury: brain vent, a single centre randomized interventional study.

Acute brain injury Cerebral autoregulation Intracranial pressure Lung protective ventilation Positive end-expiratory pressure Subarachnoid haemorrhage Transpulmonary pressure Traumatic brain injury

Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
20 03 2023
Historique:
received: 30 12 2022
accepted: 25 02 2023
entrez: 21 3 2023
pubmed: 22 3 2023
medline: 23 3 2023
Statut: epublish

Résumé

Lung protective ventilation (LPV) comprising low tidal volume (VT) and high positive end-expiratory pressure (PEEP) may compromise cerebral perfusion in acute brain injury (ABI). In patients with ABI, we investigated whether LPV is associated with increased intracranial pressure (ICP) and/or deranged cerebral autoregulation (CA), brain compensatory reserve and oxygenation. In a prospective, crossover study, 30 intubated ABI patients with normal ICP and no lung injury were randomly assigned to receive low VT [6 ml/kg/predicted (pbw)]/at either low (5 cmH We included 27 patients (intracerebral haemorrhage, traumatic brain injury, subarachnoid haemorrhage), of whom 6 reached the safety limit, which required interruption of at least one intervention. For those without intervention interruption, the ICP change from baseline to "low VT/low PEEP" and "low VT/high PEEP" were 2.2 mmHg and 2.3 mmHg, respectively, and considered clinically non-relevant. None of the interventions affected CA or oxygenation significantly. Interrupted events were associated with high baseline ICP (p < 0.001), low brain compensatory reserve (p < 0.01) and mechanical power (p < 0.05). The transpulmonary driving pressure was 5 ± 2 cmH The present study found that most patients did not experience any adverse effects of LPV, neither on ICP nor CA. However, in almost a quarter of patients, the ICP rose above the safety limit for interrupting the interventions. Baseline ICP, brain compensatory reserve, and mechanical power can predict a potentially deleterious effect of LPV and can be used to personalize ventilator settings. Trial registration NCT03278769 . Registered September 12, 2017.

Identifiants

pubmed: 36941683
doi: 10.1186/s13054-023-04383-z
pii: 10.1186/s13054-023-04383-z
pmc: PMC10026451
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Banques de données

ClinicalTrials.gov
['NCT03278769']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Subventions

Organisme : Medical Research Council
ID : MR N013433-1
Pays : United Kingdom
Organisme : Helse Nord RHF
ID : 181021

Informations de copyright

© 2023. The Author(s).

Références

J Crit Care. 2017 Apr;38:341-345
pubmed: 27914908
J Trauma. 1978 Apr;18(4):254-6
pubmed: 351206
Intensive Care Med. 2018 Nov;44(11):1914-1922
pubmed: 30291378
Intensive Care Med. 2020 May;46(5):919-929
pubmed: 31965267
JAMA. 2018 Nov 13;320(18):1872-1880
pubmed: 30357256
J Clin Monit Comput. 2022 Dec;36(6):1621-1628
pubmed: 35059914
Intensive Care Med. 2017 Jul;43(7):957-970
pubmed: 28315940
BMC Neurol. 2018 Aug 24;18(1):124
pubmed: 30143022
Neurosurgery. 1997 Jul;41(1):11-7; discussion 17-9
pubmed: 9218290
Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263
pubmed: 28459336
Acta Neurochir (Wien). 2019 Jul;161(7):1275-1284
pubmed: 31053909
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Crit Care. 2015 Dec;30(6):1263-6
pubmed: 26307004
J Neurosurg. 1977 Feb;46(2):227-32
pubmed: 319205
Stroke. 2001 Apr;32(4):891-7
pubmed: 11283388
Intensive Care Med. 2019 May;45(5):683-686
pubmed: 30778650
Intensive Care Med. 2020 Dec;46(12):2397-2410
pubmed: 33175276
Neurosurg Focus. 2007 May 15;22(5):E10
pubmed: 17613228
Am Rev Respir Dis. 1982 Nov;126(5):788-91
pubmed: 7149443
Crit Care Med. 1997 Jun;25(6):1059-62
pubmed: 9201061
Neurocrit Care. 2023 Feb;38(1):178-191
pubmed: 36071333
J Clin Med. 2021 Jun 30;10(13):
pubmed: 34209017
Front Physiol. 2021 Oct 18;12:711273
pubmed: 34733173
Intensive Care Med. 2022 Jun;48(6):649-666
pubmed: 35595999
J Neurotrauma. 2021 Oct 15;38(20):2790-2800
pubmed: 34407385
Neurosurgery. 2006 Jul;59(1):21-7; discussion 21-7
pubmed: 16823296
JAMA. 2020 Dec 22;324(24):2509-2520
pubmed: 33295981
Acta Neurochir Suppl. 2005;95:43-9
pubmed: 16463818
Crit Care. 2016 May 05;20(1):129
pubmed: 27145751
Intensive Care Med. 2016 Oct;42(10):1567-1575
pubmed: 27620287
Am J Respir Crit Care Med. 2017 May 1;195(9):1198-1206
pubmed: 28267376
Intensive Care Med. 2005 Mar;31(3):373-9
pubmed: 15668765
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Crit Care Med. 2007 Aug;35(8):1815-20
pubmed: 17568331
J Neurotrauma. 2020 May 15;37(10):1233-1241
pubmed: 31760893
Crit Care. 2013 Mar 19;17(2):219
pubmed: 23509867
BMJ Open. 2022 Mar 10;12(3):e060188
pubmed: 35273066
Neurocrit Care. 2016 Jun;24(3):332-41
pubmed: 26503512
Neurocrit Care. 2008;9(3):400-8
pubmed: 18696268
Crit Care. 2021 Oct 13;25(1):358
pubmed: 34645485
Neurocrit Care. 2017 Apr;26(2):174-181
pubmed: 27848125
Curr Opin Crit Care. 2018 Jun;24(3):216-222
pubmed: 29601320
Intensive Care Med. 2016 Sep;42(9):1360-73
pubmed: 27334266

Auteurs

Erta Beqiri (E)

Department of Clinical Neurosciences, Neurosurgery Department, University of Cambridge, Cambridge, UK.

Peter Smielewski (P)

Department of Clinical Neurosciences, Neurosurgery Department, University of Cambridge, Cambridge, UK.

Claude Guérin (C)

University of Lyon, Lyon, France.
INSERM955, Créteil, France.

Marek Czosnyka (M)

Department of Clinical Neurosciences, Neurosurgery Department, University of Cambridge, Cambridge, UK.

Chiara Robba (C)

IRCCS for Oncology and Neuroscience, Policlinico San Martino, Genoa, Italy.
Department of Surgical Science Diagnostic and Integrated, University of Genova, Genoa, Italy.

Lars Bjertnæs (L)

Department of Anaesthesia and Intensive Care, University Hospital of North Norway, Tromsø, Norway.
Department of Clinical Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Shirin K Frisvold (SK)

Department of Anaesthesia and Intensive Care, University Hospital of North Norway, Tromsø, Norway. shirin.frisvold@uit.no.
Department of Clinical Medicine, UiT the Arctic University of Norway, Tromsø, Norway. shirin.frisvold@uit.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH